Akari Therapeutics Plc RSI
Что обозначает RSI в Akari Therapeutics Plc?
RSI Akari Therapeutics Plc является 47.45
Какое определение для RSI?
Индекс относительной силы (RSI 14) - это индикатор импульса, который сравнивает величину прибылей и убытков за определенный период времени для измерения скорости и изменения движений цены ценных бумаг.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI компаний в Health Care сектор на NASDAQ по сравнению с Akari Therapeutics Plc
Что делает Akari Therapeutics Plc?
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Компании с rsi похож на Akari Therapeutics Plc
- UBS ETF (CH) - SBI Domestic Government 1-3 имеет RSI из 47.43
- Inspiration Healthcare plc имеет RSI из 47.43
- Kerr Mines имеет RSI из 47.44
- Firsthand Technology Value Fund Inc имеет RSI из 47.44
- Rogers Communications имеет RSI из 47.44
- St. Augustine Gold and Copper имеет RSI из 47.44
- Akari Therapeutics Plc имеет RSI из 47.45
- Ultra Petroleum имеет RSI из 47.46
- Gett Gold Inc имеет RSI из 47.46
- Zacatecas Silver имеет RSI из 47.46
- CK Infrastructure имеет RSI из 47.46
- Siemens AG имеет RSI из 47.46
- Jia limited имеет RSI из 47.46